Jin Medical (NASDAQ: ZJYL) director submits initial insider Form 3

Rhea-AI Filing Summary

Jin Medical International Ltd. director Franklin Oliver St Clair Jr filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing establishes his status as a director and provides a baseline ownership record, and it reports no transactions or trades in the company’s securities.

Key Figures

Reported buy transactions: 0 transactions Reported sell transactions: 0 transactions Net buy/sell shares: 0 shares

3 metrics

Reported buy transactions 0 transactions Form 3 transaction summary

Reported sell transactions 0 transactions Form 3 transaction summary

Net buy/sell shares 0 shares Form 3 netBuySellShares (neutral)

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"an initial Form 3, which is a statement of beneficial ownership for insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"when they first become reporting persons"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Franklin Oliver St Clair Jr

(Last) (First) (Middle)

C/O JIN MEDICAL INTERNATIONAL LTD.

NO. 33 LINGXIANG ROAD, WUJIN DISTRICT

(Street)

CHANGZHOU, JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Jin Medical International Ltd. [ ZJYL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Oliver St. Clair Franklin	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Jin Medical (ZJYL) Form 3 filing by Franklin Oliver St Clair Jr mean?

The Form 3 filing records Franklin Oliver St Clair Jr as a director and insider of Jin Medical International Ltd. It serves as his initial statement of beneficial ownership and establishes a baseline record of his holdings at the time he became a reporting person.

Does the Jin Medical (ZJYL) Form 3 show any stock purchases or sales by Franklin Oliver St Clair Jr?

No, the Form 3 data show no reported stock purchases, sales, option exercises, gifts, or other transactions. It is strictly an initial ownership statement, with all transaction-related counts reported as zero in the summarized data provided.

What role does Franklin Oliver St Clair Jr have at Jin Medical (ZJYL) according to this Form 3?

According to the Form 3, Franklin Oliver St Clair Jr is a director of Jin Medical International Ltd. He is not listed as an officer or ten percent owner, making this filing his initial insider ownership disclosure in that director capacity.

Why is a Form 3 important for Jin Medical (ZJYL) investors?

Form 3 is important because it identifies new insiders, such as directors, and records their beneficial ownership when they first become reporting persons. This provides transparency into who holds influential positions and establishes a baseline for tracking any future insider transactions.

Are there any derivative securities reported for Franklin Oliver St Clair Jr in the Jin Medical (ZJYL) Form 3?

No, the derivativeSummary in the provided data is empty, and derivativeTransactionCount is zero. This indicates no reportable options, warrants, or other derivative securities positions were disclosed for Franklin Oliver St Clair Jr in this initial Form 3 snapshot.